Supriya Lifescience Ltd. (SUPRIYA): Supriya Lifescience Share Price Rises 5.98% as Stock Trades at Rs 906.3

Supriya Lifescience Share Price is trading at Rs 906.3, up 5.98% today, with market capitalisation at Rs 6,882.89 crore. The move lifts Supriya Lifescience Ltd. into today’s active market conversation, even though the latest data confirms the price event but does not establish a company-specific catalyst. For readers tracking Supriya Lifescience Share Price Today, the key takeaway is simple: the stock is rising on a visible same-day gain, while the broader investment case still depends on valuation, business quality and sector backdrop. Univest data shows the move alongside a turnover of Rs 4.44 crore, giving a useful snapshot of where the stock is trading in real time. In today’s Supriya Lifescience Stock News flow, the focus is therefore on price action, not speculation, with investors watching how the share price behaves around current levels.

Supriya Lifescience Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 906.3
Previous Close	Rs 855.2
Today's Move	Rs 51.1 (+5.98%)
Open	Rs 872.85
High	Rs 922.05
Low	Rs 864.7
Turnover	Rs 4.44 crore
Market Capitalisation	Rs 6,882.89 crore
Market Cap Category	Mid Cap

Supriya Lifescience Ltd. (SUPRIYA) rose to Rs 906.3 from the previous close of Rs 855.2, a move of Rs 51.1 or 5.98%. The stock opened at Rs 872.85, reached a high of Rs 922.05, recorded a low of Rs 864.7.

Supriya Lifescience Share Price Today reflects a clear intraday rise from the previous close of Rs 855.2 to Rs 906.3, a gain of Rs 51.1 or 5.98%. The stock opened at Rs 872.85, touched a high of Rs 922.05 and a low of Rs 864.7, which shows that buyers stayed active through the move. That makes Supriya Lifescience Share Price relevant in today’s market update for investors looking at Stocks in News and Top Gainers Today. The latest price action confirms a firm share price rise, but the data stops at what happened in the market; it does not establish why the move started. For anyone scanning Supriya Lifescience Share Price Live, the range and current print show a stock that is trading well above the previous close and near the upper part of the day’s range.

Supriya Lifescience Ltd. (SUPRIYA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 6,882.89 crore
P/E Ratio	34.7x
P/B Ratio	5.63x
ROE	19.06%
ROCE	25.3%
EPS	Rs 24.65
Book Value Per Share	Rs 151.81
Dividend Yield	0.12%

Supriya Lifescience Ltd. (SUPRIYA) fundamental metrics show P/E 34.7x, P/B 5.63x, ROE 19.06%, ROCE 25.3%. These figures provide context only and are not a buy or sell signal.

Supriya Lifescience Ltd. has a market capitalisation of Rs 6882.89 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.7x, P/B at 5.63x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.06% and ROCE of 25.3%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 24.65, book value per share of Rs 151.81, dividend yield of 0.12%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	34.7x
Benchmark Median P/E	32.83x
Benchmark Average P/E	48.79x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	5.63x
Benchmark Median P/B	2.92x
Company ROE	19.06%
Benchmark Median ROE	11.78%
Company ROCE	25.3%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 6,882.89 crore
Benchmark Median Market Cap	Rs 674.09 crore

Supriya Lifescience Ltd. (SUPRIYA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Supriya Lifescience Ltd. (SUPRIYA) has a P/E ratio of 34.7x, which is above the benchmark median of 32.83x, a difference of +5.7%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Supriya Lifescience Ltd. (SUPRIYA) has a ROE of 19.06%, which is above the benchmark median of 11.78%, a difference of +61.8%. Supriya Lifescience Ltd. (SUPRIYA) has a ROCE of 25.3%, which is above the benchmark median of 13.65%, a difference of +85.35%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.67	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,41,576.41	82.59	13.68	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.58	20.55	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.19	3.18	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,820.18	24.78	4.15	19.69	21.39

Supriya Lifescience Ltd. (SUPRIYA) has a P/E ratio of 34.7x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.06% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 25.3% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Supriya Lifescience Ltd. (SUPRIYA) has a market capitalisation of Rs 6,882.89 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Supriya Lifescience

• Supriya Lifescience Share Price is up 5.98% today, making it a clear market mover in healthcare.
• The stock traded between Rs 864.7 and Rs 922.05, showing active price action around the current level.
• Its market capitalisation of Rs 6,882.89 crore keeps it in the mid-cap zone of the healthcare universe.
• P/E, P/B, ROE and ROCE give investors a straightforward fundamental read on Supriya Lifescience Share Price.
• Sector comparison shows it against a large and diverse pharmaceutical peer group, which keeps Supriya Lifescience Stock News relevant.

About Supriya Lifescience Ltd.

Supriya Lifescience Ltd. operates in Pharmaceuticals & Drugs within the Healthcare sector. The business context places it among Indian pharma companies that are typically evaluated on product quality, operating efficiency, capital returns and valuation discipline. For investors following Supriya Lifescience Share Price, the company’s market position matters because it is not being judged only on daily price changes, but also on how its earnings profile and balance-sheet metrics compare with established industry peers. Its current EPS of Rs 24.65, book value of Rs 151.81 and dividend yield of 0.12% provide a concise financial picture that helps readers understand the stock beyond the day’s move. In Supriya Lifescience Stock News coverage, the company remains relevant because it belongs to a sector where institutional and retail attention often shifts quickly when price action and fundamentals align. Univest tracks this kind of company overview in a format that helps investors stay oriented.

Frequently Asked Questions

Why is Supriya Lifescience Share Price rising today?

Ans. Supriya Lifescience Share Price is rising today because the stock is up 5.98% and trading at Rs 906.3. The latest market data confirms the move, but it does not establish a company-specific catalyst.

What is Supriya Lifescience Share Price today?

Ans. Supriya Lifescience Share Price today is Rs 906.3. It is above the previous close of Rs 855.2 and has moved higher by Rs 51.1 during the current market session.

How much did Supriya Lifescience share price rise today?

Ans. Supriya Lifescience Share Price rose 5.98% today, equal to Rs 51.1. The move took the stock from Rs 855.2 at the previous close to Rs 906.3. The intraday range extended from Rs 864.7 to Rs 922.05.

What is Supriya Lifescience market capitalisation?

Ans. Supriya Lifescience has a market capitalisation of Rs 6,882.89 crore. That places the company well above the industry median in the same pharma benchmark set. The company operates in the Healthcare sector.

Is Supriya Lifescience expensive compared with peers?

Ans. Supriya Lifescience Share Price reflects a P/E of 34.7 and P/B of 5.63. Both are above industry medians, while ROE and ROCE also compare favourably across the benchmark set.

What do Supriya Lifescience EPS and book value show?

Ans. EPS is Rs 24.65 and book value is Rs 151.81. EPS shows earnings attributable to each share, while book value reflects the accounting net worth behind each share at the current market level.

What is Supriya Lifescience dividend yield?

Ans. Supriya Lifescience Share Price is paired with a dividend yield of 0.12%. Dividend yield is a historical and current market measure, so it helps frame payout context rather than future payout certainty.

How does Supriya Lifescience compare with healthcare peers?

Ans. Supriya Lifescience Share Price compares with peers that are much larger in market cap, including Sun Pharma and Divi's Labs. Its returns on equity and capital employed are still competitive within the set.

Track Supriya Lifescience Share Price on Univest

Use Supriya Lifescience Ltd. (SUPRIYA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track Supriya Lifescience Share Price on Univest for live price updates, key ratios, 52-week levels and broader market insights. The platform also helps readers follow Supriya Lifescience Share Price Today alongside company fundamentals, sector context and peer comparison in one place. For anyone scanning Supriya Lifescience Latest News or Supriya Lifescience Share News, Univest keeps the story organised around price, valuation and business context without noise. That makes it easier to monitor how Supriya Lifescience Stock Performance develops through the trading day.